Company: AIZ
Filing Date: 2025-04-08
Form Type: DEF 14A
Source: 0001267238-25-000018
Chunk: 21

Company: ASSURANT, INC.
Filing Date: 2025-04-08
Form: DEF 14A
Chunk 21
---
ominating and Corporate Governance Committee, conducts a self-evaluation of the Board as a whole and each of its committees at least annually. Each committee also conducts a self-evaluation. This process helps inform the annual director nomination process and Board refreshment.

• Annual Board Evaluation of CEO. The Chair of the Board and the Chair of the Compensation and Talent Committee lead the evaluation process of the CEO’s performance with the Compensation and Talent Committee.

• Limits on Public Company Board and Audit Committee Service. No independent director may serve on more than four public company boards (including the Company’s Board) and directors who are also serving as a chief executive officer, including the Company’s CEO, may not serve on more than two public company boards (including the Company’s Board). No member of the Audit Committee may simultaneously serve on the audit committee of more than three public companies (including the Company’s Audit Committee), unless the Board determines that such service would not impair the effectiveness of their service on the Company’s Audit Committee. A director must seek approval of the Nominating and Corporate Governance Committee in advance of serving on the board of another entity.

• Regular Executive Sessions of Independent Directors. The independent directors hold regular executive sessions, generally at each regularly scheduled meeting of the Board and each committee, at which management, including the CEO, is not present.

#### Stockholder Rights and Engagement
• Proxy Access. A stockholder, or a group of up to 20 stockholders, owning 3% or more of the Company’s outstanding common stock continuously for at least three years, has the right to nominate and include in the Company’s proxy materials director nominees constituting the greater of two or 20% of the total number of directors, if the stockholder(s) and nominee(s) meet the requirements in the Company’s by-laws.

• Stockholder Engagement. As a part of our ongoing stockholder engagement, we continue to reach out

| 36 |     | Notice of 2025 Annual Meeting of Stockholders and Proxy Statement |

| Corporate Governance |

and engage with a wide array of institutional investors . In 2024, we continued our stockholder engagement program. Our Board Chair joined our engagement with our top institutional investors. In total, we spoke with holders of over 30% of our outstanding common stock, and highlighted board oversight and refreshment and advancements in our sustainability efforts related to talent, products and climate. We look forward to continuing this important dialogue with our investors in 2025.

• No Stockholder Rights Plan. The Company does not